Beyond Air (XAIR) Current Deferred Revenue (2019 - 2026)

Beyond Air (XAIR) posted Current Deferred Revenue of $777000.0 for Q1 2026, down 7.61% sequentially from $841000.0 in Q4 2025.

Beyond Air (XAIR) Current Deferred Revenue (2019 - 2026) Analysis & Trends

Beyond Air has reported Current Deferred Revenue for 4 years, with the latest figure at $777000.0 in Q1 2026.

Quarterly Current Deferred Revenue changed N/A year-over-year to $777000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $777000.0 (changed N/A YoY) and the FY2026 annual result came in at $777000.0, changed N/A from the prior year.
Current Deferred Revenue declined to $777000.0 in Q1 2026 per XAIR's latest filing, from $841000.0 in the prior quarter.
Over five years, Current Deferred Revenue peaked at $841000.0 in Q4 2025 and troughed at $777000.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn
10	Beyond Air	3.61 Mn	-7.30 Mn	225,000.00

Download Data